Floatz logo

Dexrazoxane

Effects of Dexrazoxane on Healthy Human

University of ArkansasSmall moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Effects of Dexrazoxane on Healthy Human cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Dexrazoxane is also rated in:

diffuse large B-cell lymphomaDormant
B
Indicative ·
60 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
B
Indicative ·
59 / 100
View asset →
blast phase chronic myelogenous leukemia, BCR-ABL1 positiveDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →